Ependymoma Terminated Phase 2 Trials for Marizomib (DB11762)

Also known as: Brain Ependymoma / Ependymoma of Brain / Ependymomas / Ependymoma (morphologic abnormality) / Ependymoma (disorder) / Ependymoma of brain (disorder)

IndicationStatusPhase
DBCOND0017183 (Ependymoma)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03727841Marizomib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord EpendymomaTreatment